Skip to main content

Subphenotypes and the De Ritis ratio for mortality risk stratification in sepsis-associated acute liver injury: a retrospective cohort study.

EClinicalMedicine2025-04-14PubMed
Total: 74.0Innovation: 7Impact: 7Rigor: 8Citation: 7

Summary

Across two ICU databases, sepsis patients with liver injury had markedly higher 30-day mortality. The De Ritis (AST/ALT) ratio most strongly stratified mortality risk: ≤1 showed no significant increase, 1–2 increased risk (HR 1.56), and ≥2 had the highest risk (HR 2.46), with external validation.

Key Findings

  • Sepsis-associated liver injury doubled 30-day mortality risk versus no SALI (HR 1.73).
  • De Ritis ratio stratified mortality: ≤1 (no significant increase), 1–2 (HR 1.56), ≥2 (HR 2.46).
  • Findings replicated in an external ICU cohort; R-factor and ALT elevation also stratified but were weaker.

Clinical Implications

Incorporate the De Ritis ratio into early assessment of sepsis with suspected liver injury to identify high-risk patients (AST/ALT ≥1), prioritize monitoring, and consider targeted interventions.

Why It Matters

A simple, widely available ratio provides robust, validated risk stratification for sepsis-associated liver injury, enabling immediate bedside application.

Limitations

  • Retrospective design with potential residual confounding.
  • AST/ALT can be influenced by extrahepatic sources (e.g., muscle injury), potentially affecting specificity.

Future Directions

Prospective validation and integration of De Ritis ratio into sepsis risk scores; evaluate whether ratio-guided protocols improve outcomes.

Study Information

Study Type
Cohort
Research Domain
Prognosis
Evidence Level
III - Large retrospective cohort with external validation.
Study Design
OTHER